🔗 Share this article

Grammy-winning R&B singer D’Angelo passed away on the fourteenth of October at 51 years old after a private battle with pancreatic cancer.

“The shining star of our household has dimmed his light for us in this life,” his relatives confirmed. “After a prolonged and courageous battle with the disease, we are heartbroken to announce that Michael D’Angelo Archer, recognized by his fans around the world as D’Angelo, has been called home.”

D’Angelo left an indelible mark on music with his pioneering modern soul style and collaborations with high-profile artists.

He released his first record, “Brown Sugar,” in 1995 to instant praise. The album achieved No. 4 on the R&B charts, went platinum soon after, and received several award nominations.

However, it was his sophomore release, “Voodoo,” in 2000 that boosted his artistic journey into the limelight. The record debuted at No. 1 on each of Billboard’s Top R&B Albums chart and the Billboard 200. He won two Grammy Awards: Best R&B Album and Outstanding Male Vocal Performance for “Untitled (How Does It Feel).”

The visual for “Untitled (How Does It Feel)” cemented D’Angelo’s standing as a icon, albeit a reluctant one, in the public consciousness. The intimate portrayal showed the singer, famously bare to his midsection, singing straight into the lens.

D’Angelo retreated from the public eye after releasing Voodoo and publicly struggled with drugs and alcohol. In 2005, he was involved in a severe vehicle accident that put him in grave health.

More than a decade later, his last record, “Black Messiah” (2014), confirmed his enduring appeal with a further top chart entry on the R&B chart and a Grammy for Best R&B Album.

Again, in his own enigmatic fashion, D’Angelo had limited public outings in the following years.

The musician was scheduled as a headliner for the 2025 music event, but his appearance was canceled, citing an “unexpected health issue.”

Although details are sparse about D’Angelo’s well-being in the months leading up to his passing, he had apparently been in the hospital for months and in hospice for a fortnight.

D’Angelo’s passing is a stark reminder of the devastating effects of pancreatic cancer, one of the deadliest and hardest to prevent types of the illness, on a gifted artist whose life was ended too soon.

“We are saddened that he can only leave cherished moments with his loved ones, but we are forever thankful for the heritage of deeply emotional music he leaves behind,” his kin said.

Pancreatic Cancer: Deadly and Rarely Preventable

Pancreatic malignancy affects the digestive organ, a tiny gland that produces insulin and plays an essential role in digestion, among other functions. The size and location of the pancreas in the body make it more difficult to identify malignancy.

Even though this cancer makes up only approximately three percent of cancer diagnoses each year in the United States, it is responsible for 7% of malignancy fatalities.

Nearly 70,000 individuals will be found to have this condition and roughly fifty-two thousand will succumb to the disease in 2025.

“Pancreatic cancer is one of the most lethal diseases, with an fast-growing mass and dismal outcomes. We have limited and poor treatment options, and a narrow opportunity to make a meaningful impact on the lives of patients,” said a cancer specialist.

Because this disease rarely causes early symptoms, it’s often diagnosed only after the disease is late-stage. Although a patient has indicators they are usually vague and may be mistaken for a number of common illnesses.

“As of yet, there is no good way to identify this malignancy in the initial phases, except for paying attention to physical changes and consulting your doctor if there are unfamiliar signs,” said a health expert.

Common symptoms of pancreatic cancer include:

• abdominal or lower back pain
• weight loss
• jaundice
• reduced hunger
• brownish urine
• pale or fatty bowel movements
• loose stools
• increased appetite or thirst
• feeling sick

At age 51, D’Angelo’s death is an exception, as this malignancy is typically found in individuals in the 65 to 75 range. However, numerous malignancies, including pancreatic cancer, have become more common among younger people.

“Pancreatic cancer identified prior to fifty is considered rare, yet concerningly, doctors are noticing a growing number of younger patients affected by this disease,” said a specialist.

Family History Affects Disease Probability

In the absence of reliable screening tools for pancreatic cancer, professionals emphasized the importance of understanding your relatives’ cancer history. Some contributing elements, such as smoking and excess weight also have an influence in the development of pancreatic cancer.

African Americans have the highest incidence of this malignancy in the U.S. and are more prone to be found to have inoperable cancer.

“The first step toward reducing one’s risk of this condition is assessing individual susceptibility. People should review their family history, hereditary factors, and health issues, such as diabetes, long-term pancreas inflammation, or obesity that may increase their susceptibility,” advised a specialist.

Inherited genetic elements are linked to as much as 10% of all pancreatic cancer instances. If a relative in your family has had this disease, you may want to consider DNA analysis.

“For people with a relative’s background of pancreatic cancer or those carrying high risk genetic mutations, screening may involve advanced imaging such as magnetic resonance imaging (MRI) or endoscopic ultrasound (EUS) to detect early changes in the pancreas,” he clarified.

For those looking to lower their chance, lifestyle changes may make a difference. The best step you can take to reduce your susceptibility of pancreatic cancer is to stop tobacco use, and if you don’t smoke, avoid exposure altogether.

Heavy alcohol consumption is associated with pancreatitis, a risk factor for this malignancy, so reducing or avoiding drinks may help reduce your risk.

Managing your body mass or shedding pounds may also help decrease your susceptibility. Individuals with obesity are 20% more likely to get pancreatic cancer. This malignancy also occurs more often in people with diabetes, and weight loss can also reduce the risk of type 2 diabetes.

In spite of this disease’s poor prognosis, there is reason for optimism.

“We are doing better with therapies and newer combination chemotherapy. There are emerging targeted therapies that are already showing results,” remarked a expert.

For numerous people, however, awareness about this uncommon but {dev